HEADER TRANSFERASE 29-SEP-11 4A31 TITLE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE (NMT) TITLE 2 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 4-421; COMPND 5 SYNONYM: N-MYRISTOYL TRANSFERASE; COMPND 6 EC: 2.3.1.97; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA MAJOR; SOURCE 3 ORGANISM_TAXID: 5664; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ACYLTRANSFERASE, TRANSFERASE, DRUG DISCOVERY, LEISHMANIASIS EXPDTA X-RAY DIFFRACTION AUTHOR D.A.ROBINSON,S.BRAND,L.A.T.CLEGHORN,S.P.MCELROY,V.C.SMITH, AUTHOR 2 I.HALLYBURTON,J.R.HARRISON,N.R.NORCROSS,S.NORVAL,D.SPINKS, AUTHOR 3 L.STOJANOVSKI,L.S.TORRIE,J.A.FREARSON,R.BRENK,A.H.FAIRLAMB, AUTHOR 4 M.A.J.FERGUSON,K.D.READ,P.G.WYATT,I.H.GILBERT REVDAT 4 20-DEC-23 4A31 1 REMARK REVDAT 3 14-FEB-18 4A31 1 JRNL REMARK REVDAT 2 25-JAN-12 4A31 1 JRNL REVDAT 1 21-DEC-11 4A31 0 JRNL AUTH S.BRAND,L.A.CLEGHORN,S.P.MCELROY,D.A.ROBINSON,V.C.SMITH, JRNL AUTH 2 I.HALLYBURTON,J.R.HARRISON,N.R.NORCROSS,D.SPINKS,T.BAYLISS, JRNL AUTH 3 S.NORVAL,L.STOJANOVSKI,L.S.TORRIE,J.A.FREARSON,R.BRENK, JRNL AUTH 4 A.H.FAIRLAMB,M.A.FERGUSON,K.D.READ,P.G.WYATT,I.H.GILBERT JRNL TITL DISCOVERY OF A NOVEL CLASS OF ORALLY ACTIVE TRYPANOCIDAL JRNL TITL 2 N-MYRISTOYLTRANSFERASE INHIBITORS. JRNL REF J. MED. CHEM. V. 55 140 2012 JRNL REFN ISSN 1520-4804 JRNL PMID 22148754 JRNL DOI 10.1021/JM201091T REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 21728 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1177 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.09 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.14 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1160 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.1870 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3342 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 97 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.77000 REMARK 3 B22 (A**2) : -0.60000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.10000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.257 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.801 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3541 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4827 ; 1.579 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 410 ; 6.378 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 170 ;34.815 ;23.706 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 555 ;15.472 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.436 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 506 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2723 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2067 ; 0.808 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3361 ; 1.505 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1474 ; 2.284 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1464 ; 3.595 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY. REMARK 4 REMARK 4 4A31 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290049814. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22941 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3H5Z REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25.9% PEG1500, 0.2 M NACL, 0.1 M REMARK 280 CACODYLATE PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.19100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -16 REMARK 465 GLY A -15 REMARK 465 SER A -14 REMARK 465 SER A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 SER A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 ARG A -3 REMARK 465 GLU A -2 REMARK 465 ASN A -1 REMARK 465 LEU A 0 REMARK 465 TYR A 1 REMARK 465 PHE A 2 REMARK 465 GLN A 3 REMARK 465 GLY A 4 REMARK 465 PRO A 5 REMARK 465 SER A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 ASP A 9 REMARK 465 ALA A 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 64 O REMARK 470 LYS A 241 CD CE NZ REMARK 470 LYS A 268 NZ REMARK 470 ASP A 316 O REMARK 470 LYS A 317 CD CE NZ REMARK 470 SER A 336 OG REMARK 470 LYS A 412 CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 SER A 298 CA CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG MET A 141 O HOH A 2128 1.86 REMARK 500 CB SER A 221 O HOH A 2186 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 135 26.65 -149.99 REMARK 500 VAL A 307 -60.78 -129.38 REMARK 500 ASP A 316 71.57 81.26 REMARK 500 LYS A 317 35.17 17.13 REMARK 500 HIS A 347 -131.68 -113.65 REMARK 500 GLU A 379 39.13 -77.09 REMARK 500 LEU A 381 -141.46 49.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1422 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CB A 1423 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYA A 1424 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4A32 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N- MYRISTOYLTRANSFERASE (NMT) REMARK 900 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND REMARK 900 RELATED ID: 4A33 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N- MYRISTOYLTRANSFERASE (NMT) REMARK 900 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND REMARK 900 RELATED ID: 4A30 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N- MYRISTOYLTRANSFERASE (NMT) REMARK 900 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND REMARK 900 RELATED ID: 2WSA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N- MYRISTOYLTRANSFERASE (NMT) REMARK 900 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND REMARK 900 (DDD85646) REMARK 900 RELATED ID: 4A2Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEISHMANIA MAJOR N- MYRISTOYLTRANSFERASE (NMT) REMARK 900 WITH BOUND MYRISTOYL-COA AND A PYRAZOLE SULPHONAMIDE LIGAND DBREF 4A31 A 5 421 UNP Q4Q5S8 Q4Q5S8_LEIMA 5 421 SEQADV 4A31 MET A -16 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 GLY A -15 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 SER A -14 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 SER A -13 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -12 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -11 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -10 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -9 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -8 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 HIS A -7 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 SER A -6 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 SER A -5 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 GLY A -4 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 ARG A -3 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 GLU A -2 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 ASN A -1 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 LEU A 0 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 TYR A 1 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 PHE A 2 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 GLN A 3 UNP Q4Q5S8 EXPRESSION TAG SEQADV 4A31 GLY A 4 UNP Q4Q5S8 EXPRESSION TAG SEQRES 1 A 438 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 438 ARG GLU ASN LEU TYR PHE GLN GLY PRO SER ASN SER ASP SEQRES 3 A 438 ALA ALA HIS ALA PHE TRP SER THR GLN PRO VAL PRO GLN SEQRES 4 A 438 THR GLU ASP GLU THR GLU LYS ILE VAL PHE ALA GLY PRO SEQRES 5 A 438 MET ASP GLU PRO LYS THR VAL ALA ASP ILE PRO GLU GLU SEQRES 6 A 438 PRO TYR PRO ILE ALA SER THR PHE GLU TRP TRP THR PRO SEQRES 7 A 438 ASN MET GLU ALA ALA ASP ASP ILE HIS ALA ILE TYR GLU SEQRES 8 A 438 LEU LEU ARG ASP ASN TYR VAL GLU ASP ASP ASP SER MET SEQRES 9 A 438 PHE ARG PHE ASN TYR SER GLU GLU PHE LEU GLN TRP ALA SEQRES 10 A 438 LEU CYS PRO PRO ASN TYR ILE PRO ASP TRP HIS VAL ALA SEQRES 11 A 438 VAL ARG ARG LYS ALA ASP LYS LYS LEU LEU ALA PHE ILE SEQRES 12 A 438 ALA GLY VAL PRO VAL THR LEU ARG MET GLY THR PRO LYS SEQRES 13 A 438 TYR MET LYS VAL LYS ALA GLN GLU LYS GLY GLU GLY GLU SEQRES 14 A 438 GLU ALA ALA LYS TYR ASP GLU PRO ARG HIS ILE CYS GLU SEQRES 15 A 438 ILE ASN PHE LEU CYS VAL HIS LYS GLN LEU ARG GLU LYS SEQRES 16 A 438 ARG LEU ALA PRO ILE LEU ILE LYS GLU ALA THR ARG ARG SEQRES 17 A 438 VAL ASN ARG THR ASN VAL TRP GLN ALA VAL TYR THR ALA SEQRES 18 A 438 GLY VAL LEU LEU PRO THR PRO TYR ALA SER GLY GLN TYR SEQRES 19 A 438 PHE HIS ARG SER LEU ASN PRO GLU LYS LEU VAL GLU ILE SEQRES 20 A 438 ARG PHE SER GLY ILE PRO ALA GLN TYR GLN LYS PHE GLN SEQRES 21 A 438 ASN PRO MET ALA MET LEU LYS ARG ASN TYR GLN LEU PRO SEQRES 22 A 438 SER ALA PRO LYS ASN SER GLY LEU ARG GLU MET LYS PRO SEQRES 23 A 438 SER ASP VAL PRO GLN VAL ARG ARG ILE LEU MET ASN TYR SEQRES 24 A 438 LEU ASP SER PHE ASP VAL GLY PRO VAL PHE SER ASP ALA SEQRES 25 A 438 GLU ILE SER HIS TYR LEU LEU PRO ARG ASP GLY VAL VAL SEQRES 26 A 438 PHE THR TYR VAL VAL GLU ASN ASP LYS LYS VAL THR ASP SEQRES 27 A 438 PHE PHE SER PHE TYR ARG ILE PRO SER THR VAL ILE GLY SEQRES 28 A 438 ASN SER ASN TYR ASN LEU LEU ASN ALA ALA TYR VAL HIS SEQRES 29 A 438 TYR TYR ALA ALA THR SER ILE PRO LEU HIS GLN LEU ILE SEQRES 30 A 438 LEU ASP LEU LEU ILE VAL ALA HIS SER ARG GLY PHE ASP SEQRES 31 A 438 VAL CYS ASN MET VAL GLU ILE LEU ASP ASN ARG SER PHE SEQRES 32 A 438 VAL GLU GLN LEU LYS PHE GLY ALA GLY ASP GLY HIS LEU SEQRES 33 A 438 ARG TYR TYR PHE TYR ASN TRP ALA TYR PRO LYS ILE LYS SEQRES 34 A 438 PRO SER GLN VAL ALA LEU VAL MET LEU HET GOL A1422 6 HET 2CB A1423 28 HET MYA A1424 63 HETNAM GOL GLYCEROL HETNAM 2CB 6-{[2-(4-METHYLPIPERAZIN-1-YL)ETHYL]AMINO}-N-(1,3,5- HETNAM 2 2CB TRIMETHYL-1H-PYRAZOL-4-YL)PYRIDINE-3-SULFONAMIDE HETNAM MYA TETRADECANOYL-COA HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN MYA MYRISTOYL-COA FORMUL 2 GOL C3 H8 O3 FORMUL 3 2CB C18 H29 N7 O2 S FORMUL 4 MYA C35 H62 N7 O17 P3 S FORMUL 5 HOH *306(H2 O) HELIX 1 1 PHE A 14 GLN A 18 5 5 HELIX 2 2 THR A 23 ILE A 30 1 8 HELIX 3 3 THR A 41 ILE A 45 5 5 HELIX 4 4 ALA A 65 TYR A 80 1 16 HELIX 5 5 SER A 93 CYS A 102 1 10 HELIX 6 6 ILE A 107 ASP A 109 5 3 HELIX 7 7 PRO A 138 LYS A 148 1 11 HELIX 8 8 GLU A 150 LYS A 156 1 7 HELIX 9 9 LYS A 173 ARG A 176 5 4 HELIX 10 10 ARG A 179 ARG A 194 1 16 HELIX 11 11 ASN A 223 ILE A 230 1 8 HELIX 12 12 PRO A 236 PHE A 242 5 7 HELIX 13 13 ASN A 244 GLN A 254 1 11 HELIX 14 14 LYS A 268 SER A 270 5 3 HELIX 15 15 ASP A 271 ASP A 284 1 14 HELIX 16 16 SER A 293 LEU A 302 1 10 HELIX 17 17 PRO A 355 ARG A 370 1 16 HELIX 18 18 ASP A 382 VAL A 387 5 6 HELIX 19 19 LYS A 412 GLN A 415 5 4 SHEET 1 AA 4 PHE A 56 TRP A 59 0 SHEET 2 AA 4 HIS A 111 ARG A 116 -1 O ALA A 113 N TRP A 59 SHEET 3 AA 4 LEU A 122 ARG A 134 -1 N LEU A 123 O VAL A 114 SHEET 4 AA 4 GLY A 289 PRO A 290 -1 O GLY A 289 N ARG A 134 SHEET 1 AB12 PHE A 56 TRP A 59 0 SHEET 2 AB12 HIS A 111 ARG A 116 -1 O ALA A 113 N TRP A 59 SHEET 3 AB12 LEU A 122 ARG A 134 -1 N LEU A 123 O VAL A 114 SHEET 4 AB12 ARG A 161 VAL A 171 -1 O ARG A 161 N LEU A 133 SHEET 5 AB12 ALA A 200 ALA A 204 1 O VAL A 201 N ILE A 166 SHEET 6 AB12 GLY A 393 TYR A 404 -1 O ARG A 400 N ALA A 204 SHEET 7 AB12 ALA A 213 SER A 221 -1 O ALA A 213 N TYR A 401 SHEET 8 AB12 VAL A 374 VAL A 378 -1 O CYS A 375 N ARG A 220 SHEET 9 AB12 LEU A 340 ALA A 351 1 O ALA A 344 N ASN A 376 SHEET 10 AB12 VAL A 319 VAL A 332 -1 O PHE A 322 N ALA A 350 SHEET 11 AB12 VAL A 308 GLU A 314 -1 O PHE A 309 N PHE A 325 SHEET 12 AB12 LEU A 264 GLU A 266 -1 O ARG A 265 N VAL A 312 SHEET 1 AC11 PHE A 56 TRP A 59 0 SHEET 2 AC11 HIS A 111 ARG A 116 -1 O ALA A 113 N TRP A 59 SHEET 3 AC11 LEU A 122 ARG A 134 -1 N LEU A 123 O VAL A 114 SHEET 4 AC11 ARG A 161 VAL A 171 -1 O ARG A 161 N LEU A 133 SHEET 5 AC11 ALA A 200 ALA A 204 1 O VAL A 201 N ILE A 166 SHEET 6 AC11 GLY A 393 TYR A 404 -1 O ARG A 400 N ALA A 204 SHEET 7 AC11 ALA A 213 SER A 221 -1 O ALA A 213 N TYR A 401 SHEET 8 AC11 VAL A 374 VAL A 378 -1 O CYS A 375 N ARG A 220 SHEET 9 AC11 LEU A 340 ALA A 351 1 O ALA A 344 N ASN A 376 SHEET 10 AC11 VAL A 319 VAL A 332 -1 O PHE A 322 N ALA A 350 SHEET 11 AC11 PHE A 88 PHE A 90 -1 O ARG A 89 N THR A 331 SHEET 1 AD 2 GLY A 289 PRO A 290 0 SHEET 2 AD 2 LEU A 122 ARG A 134 -1 O ARG A 134 N GLY A 289 CISPEP 1 PRO A 209 THR A 210 0 -15.18 SITE 1 AC1 8 VAL A 131 GLU A 165 TYR A 348 LEU A 418 SITE 2 AC1 8 VAL A 419 HOH A2148 HOH A2264 HOH A2300 SITE 1 AC2 15 VAL A 81 PHE A 88 PHE A 90 ASN A 167 SITE 2 AC2 15 THR A 203 TYR A 217 HIS A 219 PHE A 232 SITE 3 AC2 15 SER A 330 TYR A 345 ASN A 376 LEU A 421 SITE 4 AC2 15 HOH A2262 HOH A2292 HOH A2301 SITE 1 AC3 31 HIS A 12 ALA A 13 PHE A 14 TRP A 15 SITE 2 AC3 31 ASN A 79 TYR A 80 VAL A 81 PHE A 168 SITE 3 AC3 31 LEU A 169 CYS A 170 VAL A 171 ARG A 176 SITE 4 AC3 31 GLU A 177 LYS A 178 ARG A 179 LEU A 180 SITE 5 AC3 31 ALA A 181 PRO A 182 THR A 189 ASN A 193 SITE 6 AC3 31 TYR A 202 THR A 203 LEU A 208 HOH A2001 SITE 7 AC3 31 HOH A2150 HOH A2154 HOH A2157 HOH A2302 SITE 8 AC3 31 HOH A2303 HOH A2304 HOH A2305 CRYST1 47.009 90.382 52.889 90.00 111.88 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021273 0.000000 0.008543 0.00000 SCALE2 0.000000 0.011064 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020375 0.00000